As of Feb 10
| -0.045 / -2.67%|
The 3 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 5.00. The median estimate represents a +265.85% increase from the last price of 1.64.
The current consensus among 3 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.